Advanced or Metastatic Renal Cell Carcinoma Clinical Trial
Official title:
Japanese Prospective Real World Registry of Nivolumab Plus Ipilimumab in Subjects With Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma (ARCC) Categorized Into IMDC Intermediate/Poor Risks (J-ENCORE)
The purpose of the observational study is to evaluate the safety and effectiveness of combination therapy with nivolumab and ipilimumab in Japanese participants with advanced or metastatic renal cell carcinoma (aRCC) in the real-world setting in Japan.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00873210 -
Study In Patients With Kidney Cancer Treated With Sutent
|
N/A | |
Recruiting |
NCT04106349 -
Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
|